CIPO Patents = 1

Forward Citations = 90

Loading Chart...

6 inventors (with patents filed for the assignee):

Mark D Erion (5 out of 61 patents)

John A Secrist, Iii (5 out of 39 patents)

John A Montgomery (5 out of 60 patents)

4. Steve E Ealick (5 out of 8 patents)

5. Wayne C Guida (5 out of 6 patents)

6. Shri Niwas (1 out of 5 patents)

7. Steven E Ealick (0 patent)

8. Iii Secrist John A (0 patent)

5 patents: Sort by Forward Citations

1. 5189039 - 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and (1993-02-23),

2. 5008270 - 2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and (1991-04-16),

3. 5008265 - 2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and (1991-04-16),

4. 4985434 - 7-substituted derivatives of (1991-01-15),

5. 4985433 - 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and (1991-01-15),

Company Overview

Founded in 1986, Biocryst, Inc. is a biotechnology company specializing in the development of oral and small molecule drugs for rare and serious diseases. The company has a strong focus on developing innovative therapies for hereditary angioedema and other rare genetic diseases. Biocryst's research and development efforts aim to improve the lives of patients by bringing novel treatments to market. With a commitment to scientific excellence and patient-centered innovation, Biocryst is dedicated to advancing the field of biotechnology and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#48 in Birmingham, AL

#244 in Alabama

#51,644 in US

Birmingham, AL, United States of America

Biocryst, Inc.

Forward Citations = 90

6 inventors:

Mark D Erion (5 out of 61 patents)

John A Secrist, Iii (5 out of 39 patents)

John A Montgomery (5 out of 60 patents)

4. Steve E Ealick (5 out of 8 patents)

5. Wayne C Guida (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biocryst, Inc.. Retrieved from https://idiyas.com/company/biocryst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]